Transcript[00:00] IntroductionsTristan Free:Today, we’re wrapping up our series covering the article collection on artificial intelligence and machine learning in antibody development in the journal MABS. um And can you tell us a bit more about your thoughts leading into this article collection? Pin-Kuang Lai:Yeah, when we began planning this collection, AI was already transforming many areas of biology and drug discovery. And do you have any papers in the collection ah ah but that are a particular highlight for you or that you’d like to kind of highlight to the listeners ah to say, look, you’ve got to make sure you listen to this one? Many groups are moving beyond using a single data source and instead combining sequence structure, biophysical measurements, and experimental data sets to improve prediction accuracy.